Ryan B. Sartor

Gastroenterology
101 Manning Dr
Chapel Hill, NC 27514

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 144 publications

In Memoriam Kim Isaacs.

In Memoriam Kim Isaacs.

Journal: Inflammatory bowel diseases
Published: December 16, 2025

Modulating immune toxicity in ulcerative colitis using a small molecule RAB27A inhibitor.

Modulating immune toxicity in ulcerative colitis using a small molecule RAB27A inhibitor.

Journal: Inflammatory bowel diseases
Published: November 04, 2025

Reduced intestinal GLP-1 + cell numbers are associated with an inflammation-related epithelial metabolic signature.

Reduced intestinal GLP-1 + cell numbers are associated with an inflammation-related epithelial metabolic signature.

Journal: bioRxiv : the preprint server for biology
Published: October 03, 2025

Defined human Clostridia consortia reverse colitis via dual effects of tryptophan metabolites on microbiota and immunity.

Defined human Clostridia consortia reverse colitis via dual effects of tryptophan metabolites on microbiota and immunity.

Journal: Cell host & microbe
Published: August 15, 2025

Dysbiotic microbiota trigger colitis-associated colorectal cancer and imprint a distinctive bile acid profile in a PSC-IBD model.

Dysbiotic microbiota trigger colitis-associated colorectal cancer and imprint a distinctive bile acid profile in a PSC-IBD model.

Journal: Gut
Published: August 13, 2025

Presentation of the AGA Distinguished Achievement Award in Basic Science to Eugene B. Chang, MD, AGAF.

Presentation of the AGA Distinguished Achievement Award in Basic Science to Eugene B. Chang, MD, AGAF.

Journal: Gastroenterology
Published: July 30, 2025

Dietary Protein Source Mediates Colitis Pathogenesis Through Bacterial Modulation of Bile Acids.

Dietary Protein Source Mediates Colitis Pathogenesis Through Bacterial Modulation of Bile Acids.

Journal: Cellular and molecular gastroenterology and hepatology
Published: July 07, 2025

A randomized controlled trial of antibiotics targeting adherent and invasive Escherichia coli versus placebo in Crohn's disease: the TEOREM trial.

A randomized controlled trial of antibiotics targeting adherent and invasive Escherichia coli versus placebo in Crohn's disease: the TEOREM trial.

Journal: Journal of Crohn's & colitis
Published: June 13, 2025

Reduced Intestinal GLP-1+ Cell Numbers Are Associated With an Inflammation-related Epithelial Metabolic Signature.

Reduced Intestinal GLP-1+ Cell Numbers Are Associated With an Inflammation-related Epithelial Metabolic Signature.

Journal: Cellular and molecular gastroenterology and hepatology
Published: May 16, 2025

Microbiota in Gastrointestinal and Hepatic Diseases.

Microbiota in Gastrointestinal and Hepatic Diseases.

Journal: Gastroenterology clinics of North America
Published: May 10, 2025

Beyond Random Fecal Microbial Transplants: Next Generation Personalized Approaches to Normalize Dysbiotic Microbiota for Treating IBD.

Beyond Random Fecal Microbial Transplants: Next Generation Personalized Approaches to Normalize Dysbiotic Microbiota for Treating IBD.

Journal: Gastroenterology clinics of North America
Published: May 10, 2025

Adherent-invasive Escherichia coli in Crohn's disease: the 25th anniversary.

Adherent-invasive Escherichia coli in Crohn's disease: the 25th anniversary.

Journal: Gut
Published: March 17, 2025
Showing 1-12 of 144

Last Updated: 09/26/2026